News
FDA Clamps Down on Compounders, Medicaid Faces Managed Care Shifts, and CDC’s Leadership Crisis Deepens
The latest week in public health buzzed with seismic regulatory moves, evolving care-delivery structures, and a staggering blow to the nation’s premier disease-control agency. From the FDA’s tightening grip on drug compounding to Medicaid’s managed care metamorphosis and the CDC’s leadership limbo, these developments are shaping the very foundation of American health systems. Let’s unpack […]
Read more →
